ARTICLE | Company News

Quest Diagnostics, Beth Israel Deaconess Medical Center (BIDMC), Weill Cornell Medical College sales and marketing update

March 26, 2012 7:00 AM UTC

Quest launched a molecular blood test in the U.S. to identify kidney transplant rejection. The test includes RNA genetic markers forkhead box P3 (FoxP3), granzyme B (GrB; GZMB) and perforin. Quest ...